NewtekOne, Inc.: Third Quarter 2025 Financial Results Call
Category: News Total Views: 30By : Logan Wright Updated: 10-08-2025
NewtekOne, Inc. announces its upcoming conference callNewtekOne, Inc. (NASDAQ: NEWT) is gearing up for the release of its financial results for the third quarter of 2025. The company will disclose these results after the market closes on a Wednesday, a day set for October 29, 2025. This announcement comes as NewtekOne prepares to share critical insights about its financial performance with investors and stakeholders alike.Details of the conference callThe conference c... Read More
Journey Medical's Upcoming Investor Engagements in 2025
Category: News Total Views: 34By : Hannah Lewis Updated: 10-08-2025
Participating in Key Investor ConferencesJourney Medical Corporation, commonly referred to as Journey Medical, is preparing for an exciting month of October 2025, where it will actively participate in notable investor conferences. This engagement presents a valuable opportunity for investors to meet the company’s management team, gaining insights into its future prospects and growth strategy.Details of the Upcoming Conference EventsTwo key events are scheduled for Oct... Read More
FullPAC Strengthens Its Position with GOTV.com Acquisition
Category: News Total Views: 28By : Olivia Taylor Updated: 10-08-2025
FullPAC Strengthens Its Position in Voter Mobilization
FullPAC, Inc., a prominent nonpartisan technology provider, has made significant strides in the political campaign technology space by acquiring the highly desirable domain GOTV.com. This acquisition marks a pivotal moment in FullPAC's strategy to enhance its services tailored for voter mobilization. With over 5,000 political organizations and nonprofits relying on its innovative solutions, FullPAC is poised to elevate the effect... Read More
Investors May Seek Compensation for Molina Healthcare Losses
Category: News Total Views: 27By : Logan Wright Updated: 10-08-2025
Understanding Investor Rights After Financial LossesIn the world of investing, financial losses can be disheartening. If you happen to be among those who invested in Molina Healthcare, Inc. (NYSE: MOH) and experienced losses, it’s crucial to understand your rights and potential avenues for recovery. Investors in the Class Period may have been misled regarding the company's financial situation. Being informed can empower you in pursuing possible remedies.Key Allegations Agains... Read More
GT Biopharma's Phase 1 Trial Progress for Blood Cancer Treatment
Category: News Total Views: 30By : Caleb Price Updated: 10-08-2025
GT Biopharma Advances in Phase 1 Trial for Blood CancersGT Biopharma Inc. (NASDAQ: GTBP) is making notable strides in its Phase 1 trial for the drug candidate GTB-3650, aimed at treating relapsed or refractory CD33-expressing hematologic malignancies. Recent updates reveal that patient enrollment into the dose escalation cohorts is progressing as planned. The company successfully completed enrollment in the initial two cohorts, and patients in Cohort 3 have begun treatment without an... Read More